Additional information
Gummy Liquid
1797008-41-3
ACI-021714
C19H28ClN3O3
381.9
Ambient
2-8°C
Chemotherapy
Pharmaceutical Impurity Standards
4-{5-[(2-Chloro-ethyl)-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazole-2-yl}-bytyric acid isorpopyl ester (HP-1 Ester Impurity)
4-{5-[(2-Chloro-ethyl)-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazole-2-yl}-bytyric acid isorpopyl ester (HP-1 Ester Impurity)
1-Methylethyl 5-[(2-chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoate





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)